Drug Approval | October 01, 2024
Apitoria Pharma gets Form 483 with 10 observations from USFDA
The observations are of procedural in nature and will be responded to within the stipulated time
The observations are of procedural in nature and will be responded to within the stipulated time
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Lupin updates on shipment of Mirabegron ER Tablets
Eugia Pharma Specialities restarts production at terminally sterilized product lines
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The plant is yet to start commercial operations
Subscribe To Our Newsletter & Stay Updated
